(Q34631679)

3 August 2017

1 reference

title

Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients (English)

1 reference

3 August 2017

1 reference

Douglas T Dieterich

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Journal of Infectious Diseases

3 August 2017

published in

1 reference

3 August 2017

volume

185 Suppl 2

1 reference

3 August 2017

page(s)

S128-37

1 reference

Antiretroviral therapy and declining AIDS mortality in New York City

3 August 2017

cites work

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

Natural history of HIV infection in the era of combination antiretroviral therapy

21 January 2018

1 reference

Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection

21 January 2018

1 reference

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

21 January 2018

1 reference

Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival

21 January 2018

1 reference

Hepatitis C virus/human immunodeficiency virus coinfection: clinical management issues

21 January 2018

1 reference

Hepatitis C virus genotypes and quasispecies

21 January 2018

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

21 January 2018

1 reference

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

21 January 2018

1 reference

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy

21 January 2018

1 reference

Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers

21 January 2018

1 reference

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

21 January 2018

1 reference

10-Year follow-up after interferon-alpha therapy for chronic hepatitis C.

21 January 2018

1 reference

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

Viral kinetics and mathematical models

21 January 2018

1 reference

Ribavirin Induces Error-Prone Replication of GB Virus B in Primary Tamarin Hepatocytes

21 January 2018

1 reference

Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. Comité des Anti-Viraux

21 January 2018

1 reference

Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group

21 January 2018

1 reference

Ribavirin antagonizes the effect of azidothymidine on HIV replication

21 January 2018

1 reference

Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro

21 January 2018

1 reference

A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team.

21 January 2018

1 reference

Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection

21 January 2018

1 reference

Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group

21 January 2018

1 reference

Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life

21 January 2018

1 reference

Anemia and survival in HIV infection

21 January 2018

1 reference

Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patients

21 January 2018

1 reference

Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report

21 January 2018

1 reference

Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin

21 January 2018

1 reference

Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trial

21 January 2018

1 reference

Mechanisms of transfusion-induced immunosuppression

21 January 2018

1 reference

Paroxetine for the prevention of depression induced by high-dose interferon alfa

21 January 2018

1 reference

Consensus statement: anemia in HIV infection--current trends, treatment options, and practice strategies. Anemia in HIV Working Group

21 January 2018

1 reference

Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome

21 January 2018

1 reference

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

21 January 2018

1 reference

Human immunodeficiency virus type 1 activation after blood transfusion

21 January 2018

1 reference

Transfusion of blood components to persons infected with human immunodeficiency virus type 1: relationship to opportunistic infection

21 January 2018

1 reference

The Effect of Long-Term Treatment with Granulocyte Colony-Stimulating Factor on Hematopoiesis in HIV-Infected Individuals

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/340199

1 reference

3 August 2017

1 reference